" /> Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A - CISMeF





Preferred Label : Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A;

NCIt synonyms : Oncolytic Adenoviral Vector-expressing Anti-CD40 Agonistic Antibody NG-350A; Oncolytic Adenoviral Vector Expressing Anti-CD40 Antibody NG-350A;

NCIt definition : An oncolytic adenoviral vector, enadenotucirev (EnAd), that expresses a full-length agonistic anti-CD40 monoclonal antibody, with potential immunomodulating and antineoplastic activities. Upon intratumoral administration of NG-350A, enadenotucirev specifically infects and replicates in tumor cells and not in normal, noncancerous tissue, and selectively expresses the agonistic anti-CD40 antibody. The locally expressed anti-CD40 antibody targets and binds to CD40 on a variety of immune cells, including B-cells, T-cells and dendritic cells (DCs) in the tumor microenvironment (TME). This induces CD40-dependent signaling pathways, which activates these immune cells and induces a cytotoxic T-lymphocyte (CTL)-mediated antitumor immune response and leads to tumor cell death. CD40, a cell surface receptor and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on various immune cells and plays a key role in the activation of the immune system.;

Molecule name : NG-350A; NG 350A;

NCI Metathesaurus CUI : CL951598;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.